NovaBridge Biosciences (NASDAQ: NBP) today announced that updated results from the Phase 1b combination study of givastomig, a Claudin 18.2 (CLDN18.2) x 4-1BB bispecific antibody, in combination with ...
DARTMOUTH, FAIRHAVEN, FALL RIVER, LAKEVILLE, NEW BEDFORD, SEEKONK, TAUNTON and WAREHAM, Mass — Southcoast Health is pleased ...
Obatala Sciences, a New Orleans-based biotechnology company, is establishing its first East Coast operation in Charleston ...
Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...
The ranking, based on the Stanford-Elsevier global database of scientific researchers, uses citation-based indicators and a ...
Corporation, a global provider of life science tools, reagents and diagnostic products, today announced the opening of a new ...
Qosina, a global supplier of stock components, custom solutions and regulatory services for the medical device and life sciences industries, is proud to sponsor BayCath Medical’s Innovation Week, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results